oxazoles has been researched along with abt-199 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brors, B; Huber, W; Hüllein, J; Kurilov, R; Lee, KS; Lukas, M; Oleś, M; Sellner, L; Tomska, K; Wagner, L; Walther, T; Zenz, T | 1 |
| Carter, MJ; Cox, KL; Cragg, MS; Cummin, TEC; Dunning, L; English, VL; Fell, R; Johnson, PWM; Ma, Y; Murray, TD; Packham, G; Powell, B; Turaj, AH | 1 |
2 other study(ies) available for oxazoles and abt-199
| Article | Year |
|---|---|
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.
Topics: Acetanilides; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Burkitt Lymphoma; Cell Line, Tumor; Drug Combinations; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles | 2018 |
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Mice; Nerve Tissue Proteins; Oxazoles; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyridines; Pyrroles; Receptors, Cell Surface; Sulfonamides | 2020 |